Soriatane© (Acitretin) - A - Detailing from Skin Therapy Letter

 

Soriatane© (Acitretin)

 

 

  Content:

SIDE EFFECTS, SAFETY AND RISKS

 

 

Side Effects

Skin

  • alopecia
  • chapped lips
  • dry mucus
  • membranes
  • pruritus
  • peeling of eyelids, fingertips, palms and soles
  • photosensitivity

Liver

  • transient elevation of serum transaminases
  • lactic dehydrogenase

Lipids

  • elevated serum triglycerides
  • elevated cholesterol
  • decreased high-density lipoprotein

Bones/muscles

  • arthralgia
  • myalgia
  • diffuse hyperostosis of the spine
  • muscle stiffness

Ocular

  • eye irritation
  • blepharitis
  • photophobia
  • conjunctivitis

Other

  • headaches
  • nausea
  • anemia
  • leukemia

Minimizing Side Effects

  • Many side effects of the skin are dose related, occurring within the first few days of therapy, and are reversible when treatment is terminated
  • They also occur particularly with high initial doses during treatment and then after at least 2 years off-therapy (after a pregnancy)
  • Liberal use of emollients and periodic use of corticosteroids can help with skin dryness
  • Hair loss is a dose-related effect and is reversible within 2 months after discontinuing therapy or a significant dose reduction
  • Hair loss and paronychia may occur with high initial doses of acitretin (greater than 50 mg/day)

Safety

  • Not to be used by women who are, or intend to become, pregnant during treatment, and for two years following discontinuation of treatment (some of the literature says 3 years…)
  • If a woman of childbearing age takes acitretin, she must use two forms of reliable birth control and have monthly pregnancy tests
  • All food, drinks or medicines containing alcohol must be avoided during treatment and for at least two months after treatment is stopped
  • Patients must not exceed the minimum recommended daily allowance of vitamin A due to additive toxic effects and increased risk of intracranial hypertension


Next:   Monitoring